secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aveanna Healthcare Holdings, Inc. (AVAH)
CIK:        0001832332
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0000950170-23-040917
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aveanna Q2 revenue up 6.5% to $472M; raises full-year guidance
--------------------------------------------------------------

- Revenue $471.9M (+6.5% YoY); net income $25.6M vs loss $473.9M (absence of $470.2M goodwill impairment).
- Adjusted EBITDA $35.8M (-3.2% YoY, +25.6% seq.); margin 7.6% vs 8.3% prior year.
- Full-year 2023 revenue guidance raised to $1,850M-$1,860M; Adj. EBITDA guidance $132M-$135M.
- PDS segment revenue up $29.6M; HHH segment down $6.0M; Medical Solutions up $5.3M.
- Cash $28M; revolver undrawn with $162M capacity; securitization facility extended to July 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832332/000095017023040917/0000950170-23-040917-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832332/000095017023040917/avah-20230810.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-040917

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer